These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 25327882)
1. Regulatory/effector T-cell ratio is reduced in coronary artery disease. Emoto T; Sasaki N; Yamashita T; Kasahara K; Yodoi K; Sasaki Y; Matsumoto T; Mizoguchi T; Hirata K Circ J; 2014; 78(12):2935-41. PubMed ID: 25327882 [TBL] [Abstract][Full Text] [Related]
2. Resting and Activated Natural Tregs Decrease in the Peripheral Blood of Patients with Atherosclerosis. Yazdani M; Khosropanah S; Hosseini A; Doroudchi M Iran J Immunol; 2016 Dec; 13(4):249-262. PubMed ID: 27999237 [TBL] [Abstract][Full Text] [Related]
3. Aging disturbs the balance between effector and regulatory CD4+ T cells. van der Geest KS; Abdulahad WH; Tete SM; Lorencetti PG; Horst G; Bos NA; Kroesen BJ; Brouwer E; Boots AM Exp Gerontol; 2014 Dec; 60():190-6. PubMed ID: 25449852 [TBL] [Abstract][Full Text] [Related]
4. Micro-inflammation characterized by disturbed Treg/Teff balance with increasing sIL-2R in patients with type 2 diabetes. Cai B; Zhang J; Zhang M; Li L; Feng W; An Z; Wang L Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):214-9. PubMed ID: 23595796 [TBL] [Abstract][Full Text] [Related]
5. CD45RA-Foxp3(high) activated/effector regulatory T cells in the CCR7 + CD45RA-CD27 + CD28+central memory subset are decreased in peripheral blood from patients with rheumatoid arthritis. Matsuki F; Saegusa J; Miyamoto Y; Misaki K; Kumagai S; Morinobu A Biochem Biophys Res Commun; 2013 Sep; 438(4):778-83. PubMed ID: 23747721 [TBL] [Abstract][Full Text] [Related]
6. Reduction of peripheral regulatory T cells in active rheumatoid arthritis patients with coronary artery disease. Wang Y; Su R; Li B; Guo Q; Hu F; Yu X; Ma M; Wang L; Gao C; Li X; Wang C BMC Immunol; 2021 Dec; 22(1):76. PubMed ID: 34915859 [TBL] [Abstract][Full Text] [Related]
7. Foxp3(high) and Foxp3(low) Treg cells differentially correlate with T helper 1 and natural killer cells in peripheral blood. Lee SK; Kim JY; Jang BW; Hur SE; Na BJ; Lee M; Fukui A; Gilman-Sachs A; Kwak-Kim J Hum Immunol; 2011 Aug; 72(8):621-6. PubMed ID: 21600259 [TBL] [Abstract][Full Text] [Related]
8. Low expression of CD39(+) /CD45RA(+) on regulatory T cells (Treg ) cells in type 1 diabetic children in contrast to high expression of CD101(+) /CD129(+) on Treg cells in children with coeliac disease. Åkesson K; Tompa A; Rydén A; Faresjö M Clin Exp Immunol; 2015 Apr; 180(1):70-82. PubMed ID: 25421756 [TBL] [Abstract][Full Text] [Related]
9. [Study on ratio imbalance of peripheral blood Th17/Treg cells in patients with rheumatoid arthritis]. Niu Q; Huang ZC; Cai B; Wang LL; Feng WH Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Mar; 26(3):267-9, 272. PubMed ID: 20230694 [TBL] [Abstract][Full Text] [Related]
10. Immune regulatory cells and IL17-producing lymphocytes in patients with benign and malignant salivary gland tumors. Haghshenas MR; Khademi B; Faghih Z; Ghaderi A; Erfani N Immunol Lett; 2015 Apr; 164(2):109-16. PubMed ID: 25739075 [TBL] [Abstract][Full Text] [Related]
11. CD4⁺Foxp3⁺ Treg and its ICOS⁺ subsets in patients with myocardial infarction. Ghourbani Gazar S; Andalib A; Hashemi M; Rezaei A Iran J Immunol; 2012 Mar; 9(1):53-60. PubMed ID: 22426168 [TBL] [Abstract][Full Text] [Related]
12. Impairments in Peripheral Blood T Effector and T Regulatory Lymphocytes in Bipolar Disorder Are Associated with Staging of Illness and Anti-cytomegalovirus IgG Levels. Maes M; Nani JV; Noto C; Rizzo L; Hayashi MAF; Brietzke E Mol Neurobiol; 2021 Jan; 58(1):229-242. PubMed ID: 32914395 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of CD4+ CD25+ FoxP3+ regulatory T cells during treatment of patients with brucellosis. Hasanjani Roushan MR; Bayani M; Soleimani Amiri S; Mohammadnia-Afrouzi M; Nouri HR; Ebrahimpour S J Biol Regul Homeost Agents; 2016; 30(3):675-682. PubMed ID: 27655484 [TBL] [Abstract][Full Text] [Related]
14. Circulating CD4+CD25hiCD127lo regulatory T-Cell levels do not reflect the extent or severity of carotid and coronary atherosclerosis. Ammirati E; Cianflone D; Banfi M; Vecchio V; Palini A; De Metrio M; Marenzi G; Panciroli C; Tumminello G; Anzuini A; Palloshi A; Grigore L; Garlaschelli K; Tramontana S; Tavano D; Airoldi F; Manfredi AA; Catapano AL; Norata GD Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1832-41. PubMed ID: 20539016 [TBL] [Abstract][Full Text] [Related]
15. Expression of activation antigens on lymphocyte surface and circulating platelet-leukocyte aggregates in ischaemic heart disease. Czyz A; Kołacz E; Angerer D; Zawilska K Kardiol Pol; 2005 Mar; 62(3):189-200; discussion 201. PubMed ID: 15830013 [TBL] [Abstract][Full Text] [Related]
16. Dysregulated CD4+ T cells from SLE-susceptible mice are sufficient to accelerate atherosclerosis in LDLr-/- mice. Wilhelm AJ; Rhoads JP; Wade NS; Major AS Ann Rheum Dis; 2015 Apr; 74(4):778-85. PubMed ID: 24395554 [TBL] [Abstract][Full Text] [Related]
17. Activation-induced FOXP3 isoform profile in peripheral CD4+ T cells is associated with coronary artery disease. Lundberg AK; Jonasson L; Hansson GK; Mailer RKW Atherosclerosis; 2017 Dec; 267():27-33. PubMed ID: 29100058 [TBL] [Abstract][Full Text] [Related]
18. Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation. Hoffmann P; Boeld TJ; Eder R; Huehn J; Floess S; Wieczorek G; Olek S; Dietmaier W; Andreesen R; Edinger M Eur J Immunol; 2009 Apr; 39(4):1088-97. PubMed ID: 19283780 [TBL] [Abstract][Full Text] [Related]
19. The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells. Schneider A; Rieck M; Sanda S; Pihoker C; Greenbaum C; Buckner JH J Immunol; 2008 Nov; 181(10):7350-5. PubMed ID: 18981158 [TBL] [Abstract][Full Text] [Related]
20. Reciprocal CD4+ T-cell balance of effector CD62Llow CD4+ and CD62LhighCD25+ CD4+ regulatory T cells in small cell lung cancer reflects disease stage. Koyama K; Kagamu H; Miura S; Hiura T; Miyabayashi T; Itoh R; Kuriyama H; Tanaka H; Tanaka J; Yoshizawa H; Nakata K; Gejyo F Clin Cancer Res; 2008 Nov; 14(21):6770-9. PubMed ID: 18980970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]